Nuo Therapeutics Inc.

12/17/2025 | Press release | Distributed by Public on 12/17/2025 10:09

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.
On December 16, 2025, Nuo Therapeutics, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders. The following matters were considered and voted upon:
1.
To elect four directors to serve on the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders or until each successor is duly elected and qualified;
2.
To ratify the appointment of MaloneBailey LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.
To approve, on an advisory basis, the compensation of the Company's named executive officers.
The results of the vote were as follows:
1.
Election of Directors
For
Withheld
Broker Non-Votes
David E. Jorden
33,688,602
4,962
2,237,142
Paul D. Mintz
33,686,279
7,285
2,237,142
Scott M. Pittman
33,686,279
7,285
2,237,142
C. Eric Winzer
33,658,723
34,841
2,237,142
For
Against
Abstain
Broker Non-Votes
2.
To ratify the appointment of MaloneBailey LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025
35,917,807
12,899
0
0
For
Against
Abstain
Broker Non-Votes
3.
To approve, on an advisory basis, the compensation of the Company's named executive officers
33,653,458
40,106
0
2,237,142
Nuo Therapeutics Inc. published this content on December 17, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 17, 2025 at 16:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]